U.S. Biologics Contract Manufacturing Market Size & Outlook

Name: U.S. Biologics Contract Manufacturing Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The biologics contract manufacturing market in the United States is expected to reach a projected revenue of US$ 18,282.7 million by 2030. A compound annual growth rate of 10.6% is expected of the United States biologics contract manufacturing market from 2025 to 2030.

U.S. biologics contract manufacturing product outlook (Revenue, USD million, 2018-2030)
- Vaccines
- Monoclonal Antibodies (mAbs)
- Recombinant Protein
- Antisense, RNAi, & Molecular Therapy
- Others
U.S. biologics contract manufacturing indication outlook (Revenue, USD million, 2018-2030)
- Autoimmune Diseases
- Metabolic Diseases
- Neurology
- Infectious Diseases
- Oncology
- Cardiovascular Disorders (CVDs)
- Others

U.S. Biologics Contract Manufacturing Market Size & Outlook

Sign up - it's easy, and free!